Evidence map›Paper›PMID 33469150›Full record

ArticleCommunications biology2021

Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson's disease.

Angeliki Zarkali, Peter McColgan, Louise-Ann Leyland, Andrew J Lees, Geraint Rees, Rimona S Weil

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Dopamine alters functional gradients in Parkinson's disease.Imaging neuroscience (Cambridge, Mass.) · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Angeliki ZarkaliDementia Research Centre, University College London, 8-11 Queen Square, London, WC1N 3AR, UK. a.zarkali@ucl.ac.uk.ORCID 0000-0003-2808-072X
Peter McColganHuntington's Disease Centre, University College London, Russell Square House, London, WC1B 5EH, UK.
Louise-Ann LeylandDementia Research Centre, University College London, 8-11 Queen Square, London, WC1N 3AR, UK.
Andrew J LeesReta Lila Weston Institute of Neurological Studies, 1 Wakefield Street, London, WC1N 1PJ, UK.
Geraint ReesInstitute of Cognitive Neuroscience, University College London, 17-19 Queen Square, London, WC1N 3AR, UK.ORCID 0000-0002-9623-7007
Rimona S WeilDementia Research Centre, University College London, 8-11 Queen Square, London, WC1N 3AR, UK.
UK Dementia Research Institute · GBWellcome Centre for Human Neuroimaging · GBHuntington's Disease Association · GB

Funding

Wellcome Trust 201567/Z/16/ZWellcome Trust 205167/Z/16/Z
6 · The paper itself

Abstract

Parkinson's dementia is characterised by changes in perception and thought, and preceded by visual dysfunction, making this a useful surrogate for dementia risk. Structural and functional connectivity changes are seen in humans with Parkinson's disease, but the organisational principles are not known. We used resting-state fMRI and diffusion-weighted imaging to examine changes in structural-functional connectivity coupling in patients with Parkinson's disease, and those at risk of dementia. We identified two organisational gradients to structural-functional connectivity decoupling: anterior-to-posterior and unimodal-to-transmodal, with stronger structural-functional connectivity coupling in anterior, unimodal areas and weakened towards posterior, transmodal regions. Next, we related spatial patterns of decoupling to expression of neurotransmitter receptors. We found that dopaminergic and serotonergic transmission relates to decoupling in Parkinson's overall, but instead, serotonergic, cholinergic and noradrenergic transmission relates to decoupling in patients with visual dysfunction. Our findings provide a framework to explain the specific disorders of consciousness in Parkinson's dementia, and the neurotransmitter systems that underlie these.

Indexed as

AgedBrainBrain MappingCognitive DysfunctionFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeural PathwaysParkinson DiseaseStructure-Activity Relationship

Identifiers

PMID33469150
PMCPMC7815846
OpenAlexW3121199581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.